FY2024 Earnings Estimate for UNH Issued By Cantor Fitzgerald

UnitedHealth Group Incorporated (NYSE:UNHFree Report) – Cantor Fitzgerald boosted their FY2024 EPS estimates for shares of UnitedHealth Group in a research note issued to investors on Monday, December 9th. Cantor Fitzgerald analyst S. James now forecasts that the healthcare conglomerate will earn $27.60 per share for the year, up from their previous estimate of $27.56. Cantor Fitzgerald has a “Overweight” rating and a $644.00 price objective on the stock. The consensus estimate for UnitedHealth Group’s current full-year earnings is $27.63 per share.

UNH has been the subject of several other reports. Barclays upped their price objective on shares of UnitedHealth Group from $603.00 to $655.00 and gave the stock an “overweight” rating in a report on Wednesday, November 27th. TD Cowen upped their price objective on shares of UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a report on Friday, October 18th. Oppenheimer upped their price objective on shares of UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. Deutsche Bank Aktiengesellschaft increased their price target on shares of UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a report on Tuesday, December 3rd. Finally, Stephens increased their price target on shares of UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a report on Thursday, December 5th. Three investment analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $626.84.

View Our Latest Stock Analysis on UNH

UnitedHealth Group Stock Performance

Shares of UNH opened at $565.39 on Tuesday. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. The company’s fifty day moving average is $586.36 and its 200-day moving average is $559.39. The firm has a market cap of $520.31 billion, a price-to-earnings ratio of 36.82, a price-to-earnings-growth ratio of 1.61 and a beta of 0.58. UnitedHealth Group has a 12 month low of $436.38 and a 12 month high of $630.73.

UnitedHealth Group (NYSE:UNHGet Free Report) last announced its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, topping the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The company had revenue of $100.82 billion for the quarter, compared to analyst estimates of $99.14 billion. During the same quarter in the prior year, the business posted $6.56 EPS. UnitedHealth Group’s quarterly revenue was up 9.2% on a year-over-year basis.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be given a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.49%. The ex-dividend date is Monday, December 9th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 54.72%.

Institutional Investors Weigh In On UnitedHealth Group

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. PineStone Asset Management Inc. grew its position in shares of UnitedHealth Group by 130.9% during the 2nd quarter. PineStone Asset Management Inc. now owns 1,318,475 shares of the healthcare conglomerate’s stock worth $671,447,000 after buying an additional 747,354 shares during the period. QV Investors Inc. grew its position in shares of UnitedHealth Group by 33.8% during the 2nd quarter. QV Investors Inc. now owns 66,494 shares of the healthcare conglomerate’s stock worth $33,863,000 after buying an additional 16,780 shares during the period. ORG Partners LLC boosted its stake in UnitedHealth Group by 1,538.2% during the 2nd quarter. ORG Partners LLC now owns 2,490 shares of the healthcare conglomerate’s stock worth $1,234,000 after acquiring an additional 2,338 shares during the last quarter. Addenda Capital Inc. boosted its stake in UnitedHealth Group by 2.8% during the 2nd quarter. Addenda Capital Inc. now owns 25,599 shares of the healthcare conglomerate’s stock worth $13,037,000 after acquiring an additional 696 shares during the last quarter. Finally, Tsfg LLC boosted its stake in UnitedHealth Group by 10.6% during the 2nd quarter. Tsfg LLC now owns 386 shares of the healthcare conglomerate’s stock worth $197,000 after acquiring an additional 37 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Company Profile

(Get Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Recommended Stories

Earnings History and Estimates for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.